Mouse Dermal Fibroblasts
A c t a 2 P o s t n E l n C t g f Shown are further representative images other than the ones shown in Figure 1G (A) and quantification of MMP1 and α-SMA average fluorescence signal intensity per cell per field (B). Scale bar 50 μm. n(fields per condition) = 8, mean ± SEM, one-way ANOVA/Dunnett's test, * p<0.05, ** p<0.005, *** p<0.001. (C and D) RT-qPCR analysis of the indicated CAF effector genes in a different HDF strain from the one analyzed in Figures 1D and 1E , plus/minus treatment with FGF2, TGFβ1 or both. Values are expressed as Log10 ratios of treated versus untreated HDFs. Genes are grouped in TGFβ1-(C) and FGF2-(D) induced genes. n(independent experiments) = 3, mean ± SEM, repeated-ANOVA/Dunnett's test, * p<0.05, ** p<0.005, *** p<0.001. (E) RT-qPCR analysis of the indicated CAF effector genes in mouse dermal fibroblasts (from C57BL/6 wild-type mice) plus/minus treatment with FGF2, TGFβ1 or the combination of both. Values are expressed as Log10 ratios of treated versus untreated fibroblasts. Genes are divided in TGFβ1-(left) and FGF2-(right) induced genes. n(independent experiments) = 3, mean ± SEM, repeated-ANOVA/Dunnett's test, * p<0.05, ** p<0.005, *** p<0.001. (F) RT-qPCR analysis of the indicated CAF effector genes in HDFs plus/minus treatment with FGF2, FGF5, FGF9 and FGF10. Values are expressed as Log10 ratios of treated versus untreated HDFs. Genes are grouped in TGFβ1-and FGF2-induced genes. n(independent experiments) = 3, mean ± SEM, repeated-ANOVA/Dunnett's test, * p<0.05, ** p<0.005, *** p<0.001. (C) GSEA as the one performed in panel A and B, run against two gene sets derived from published RNA-seq expression profiles of TGFβ1-treated HDFs (GEO accession GSE79621). Positively and negatively differentially expressed genes (Absolute log2FC ≥ 0.58, p-value ≤ 0.05) were used to build TGFβ1_UP (left) and TGFβ1_DOWN (right) gene sets respectively. The complete lists of genes that they comprise are shown in Table S2 . (H) RT-qPCR analysis of ETV1 in HDFs treated with indicated recombinant growth factors/cytokines described in Figure  1A . Values are expressed as Log10 of the ratio of treated versus untreated HDFs. n(HDF strains) = 3, mean ± SEM, repeated-ANOVA with Dunnett's multiple comparison test, *** p<0.001. (I) RT-qPCR analysis of ETV1 in HDFs plus/minus CRISPR-mediated TP53 gene deletion and infection with a DNFGFR1-expressing lentivirus versus empty-vector control as in Figure S2C . Data shown are from one out of two experiments with similar results. Figure 4D and 4E) with antibodies against vimentin (cyan) and pan-keratin (red). Shown are full scans of the lesions (F) and representative high magnification images (G). Scale bars 500 μm (F) and 10 μm (G). (H) Immunofluorescence analysis with an antibody against pan-keratin (red) of two desmoplastic versus two non-desmoplastic SCC lesions, followed by selection of pan-keratin-positive islands (left, white selections) and calculation of their perimeter/area average ratio per field to evaluate the invasion pattern (right). n(fields per lesion) = 8, mean ± SEM, two-tailed unpaired t-test of combined desmoplastic versus non-desmoplastic SCCs, *** p<0.001. Scale bars 100 μm. (I) Immunohistochemistry analysis for CD68 on the same SCC lesions described in the previous panel. Shown are representative images (left) and quantifications of CD68-positive cells per field (right). n(fields per lesion) = 8, mean ± SEM, two-tailed unpaired t-test of combined desmoplastic versus non-desmoplastic SCCs, *** p<0.001. Scale bars 100 μm. (A) 2D co-cultures of CAL27 cells in 1:1 ratio with DNFGFR1-or DNTGFBR2-expressing HDFs versus controls. Cancer cell proliferation was assessed by EdU incorporation (cyan) and double immunofluorescence analysis for pan-keratin (red) and vimentin (green) for CAL27 and HDF cell identification respectively. Shown are representative images, while the quantification of EdU-positive CAL27 cells is reported in Figure 5B . Scale bar 100 μm.
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Conditioned Medium on other HDFs
(B) Sphere forming assays of CAL27 cells admixed in 1:1 ratio with DNFGFR1-or DNTGFBR2-expressing HDFs versus controls and grown on Matrigel. Shown are representative images, while the quantification of number of spheres per field for each condition is reported in Figure 5D . Scale bar 500 μm. 
